Upper-Airway Stimulation for Obstructive Sleep Apnea
Upper-Airway Stimulation for Obstructive Sleep Apnea
复制标题
DOI:
10.1056/nejmoa1308659
复制
发表时间:
2014-01-09
影响因子:
158.5
通讯作者:
Strohl, Kingman P.
中科院分区:
文献类型:
--
作者:
Strollo, Patrick J., Jr.;Soose, Ryan J.;Strohl, Kingman P.
BACKGROUNDObstructive sleep apnea is associated with considerable health risks. Although continuous positive airway pressure (CPAP) can mitigate these risks, effectiveness can be reduced by inadequate adherence to treatment. We evaluated the clinical safety and effectiveness of upper-airway stimulation at 12 months for the treatment of moderate-to-severe obstructive sleep apnea.METHODSUsing a multicenter, prospective, single-group, cohort design, we surgically implanted an upper-airway stimulation device in patients with obstructive sleep apnea who had difficulty either accepting or adhering to CPAP therapy. The primary outcome measures were the apnea-hypopnea index (AHI; the number of apnea or -hypopnea events per hour, with a score of >= 15 indicating moderate-to-severe apnea) and the oxygen desaturation index (ODI; the number of times per hour of sleep that the blood oxygen level drops by >= 4 percentage points from baseline). Secondary outcome measures were the Epworth Sleepiness Scale, the Functional Outcomes of Sleep Questionnaire (FOSQ), and the percentage of sleep time with the oxygen saturation less than 90%. Consecutive participants with a response were included in a randomized, controlled therapy-withdrawal trial.RESULTSThe study included 126 participants; 83% were men. The mean age was 54.5 years, and the mean body-mass index (the weight in kilograms divided by the square of the height in meters) was 28.4. The median AHI score at 12 months decreased 68%, from 29.3 events per hour to 9.0 events per hour (P